Impact of Post-Intervention Minimal Stent Area on 9-Month Follow-Up Patency of Paclitaxel-Eluting Stents. An Integrated Intravascular Ultrasound Analysis From the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials

JACC: Cardiovascular Interventions

Volumn 2, Issue 12, 2009, Pages 1269-1275

  Doi, Hiroshi ^a   Maehara, Akiko ^a   Mintz, Gary S ^a   Yu, Alan ^b   Wang, Hong ^b   Mandinov, Lazar ^b   Popma, Jeffrey J ^c   Ellis, Stephen G ^d   Grube, Eberhard ^e   Dawkins, Keith D ^b   Weissman, Neil J ^f   Turco, Mark A ^g   Ormiston, John A ^h   Stone, Gregg W ^a  

^a NewYork Presbyterian Hospital   (United States)

^b BOSTON SCIENTIFIC CORPORATION   (United States)

^c ST ELIZABETH'S MEDICAL CENTER   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e Heart Center Siegburg   (Germany)

^f WASHINGTON HOSPITAL CENTER   (United States)

^g WASHINGTON ADVENTIST HOSPITAL   (United States)

^h AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

in stent restenosis; intravascular ultrasound; paclitaxel eluting stent; stent expansion

Indexed keywords

PACLITAXEL;

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CORONARY RISK; DRUG ELUTING STENT; FOLLOW UP; HEART INJURY; HIGH RISK PATIENT; HUMAN; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; MEDICAL PARAMETERS; MINIMAL STENT AREA; POSTOPERATIVE CARE; PREDICTOR VARIABLE; PRIORITY JOURNAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY RESTENOSIS; DOUBLE-BLIND METHOD; DRUG-ELUTING STENTS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; ODDS RATIO; PACLITAXEL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; STENTS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 72149093190     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.005     Document Type: Article

References (15)

1. Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
2. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
3. Sonoda S., Morino Y., Ako J., et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 43 (2004) 1959-1963
4. Hong M.K., Mintz G.S., Lee C.W., et al. Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 27 (2006) 1305-1310
5. Okumura M., Ozaki Y., Ishii J., et al. Restenosis and stent fracture following sirolimus-eluting stent (SES) implantation. Circ J 71 (2007) 1669-1677
6. Stone G.W., Ellis S.G., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 294 (2005) 1215-1223
7. Dawkins K.D., Grube E., Guagliumi G., et al. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Circulation 112 (2005) 3306-3313
8. Ormiston J., Mahmud E., Turco M.A., et al. Direct stenting with the TAXUS Liberte drug-eluting stent. J Am Coll Cardiol Intv 1 (2008) 150-160
9. Turco M.A., Ormiston J.A., Popma J.J., et al. Polymer-based, paclitaxel-eluting TAXUS Liberte stent in de novo lesions: the pivotal TAXUS ATLAS trial. J Am Coll Cardiol 49 (2007) 1676-1683
10. Weissman N.J., Ellis S.G., Grube E., et al. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 28 (2007) 1574-1582
11. Castagna M.T., Mintz G.S., Leiboff B.O., et al. The contribution of "mechanical" problems to in-stent restenosis: an intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions. Am Heart J 142 (2001) 970-974
12. Morino Y., Honda Y., Okura H., et al. An optimal diagnostic threshold for minimal stent area to predict target lesion revascularization following stent implantation in native coronary lesions. Am J Cardiol 88 (2001) 301-303
13. Cervinka P., Costa M.A., Angiolillo D.J., et al. Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study. Catheter Cardiovasc Interv 67 (2006) 846-851
14. Petronio A.S., De Carlo M., Branchitta G., et al. Randomized comparison of sirolimus and paclitaxel drug-eluting stents for long lesions in the left anterior descending artery: an intravascular ultrasound study. J Am Coll Cardiol 49 (2007) 539-546
15. de Ribamar Costa Jr. J., Mintz G.S., Carlier S.G., et al. Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 153 (2007) 297-303